Literature DB >> 16344618

Vasculitis and systemic infections.

Alicia Rodríguez-Pla1, John H Stone.   

Abstract

PURPOSE OF REVIEW: In recent years, many investigators have focused on potential associations between infections and vascular inflammation. We review the principal pathogenic mechanisms that have been implicated for possible roles in the vascular inflammation initiated by infectious agents. We also summarize the most important literature related to this topic. RECENT
FINDINGS: A novel theory known as autoantigen complementarity suggests that an infectious agent could trigger antineutrophil cytoplasmic antibody-associated vasculitis. Several recent studies investigating the presence of parvovirus B19 and herpesviruses in temporal arteries with giant cell arteritis have yielded contradictory results. A recent study has identified higher frequency of a novel human virus, the 'New Haven coronavirus', in respiratory secretions of children with Kawasaki disease. Many case reports have suggested potential relationships between human pathogens and vasculitis.
SUMMARY: There remains considerable interest in the possibilities of primary vasculitic syndromes caused in some fashion by infection. With the exception of a few well sustained associations - for example hepatitis B or C with known vasculitic syndromes - most of the purported links between microbial agents and primary vasculitides remain speculative.

Entities:  

Mesh:

Year:  2006        PMID: 16344618     DOI: 10.1097/01.bor.0000197999.58073.2e

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  19 in total

Review 1.  [Childhood vasculitis].

Authors:  J B Kümmerle-Deschner; J Thomas; S M Benseler
Journal:  Z Rheumatol       Date:  2015-12       Impact factor: 1.372

Review 2.  Infectious serologies and autoantibodies in hepatitis C and autoimmune disease-associated mixed cryoglobulinemia.

Authors:  Merav Lidar; Noga Lipschitz; Nancy Agmon-Levin; Pnina Langevitz; Ori Barzilai; Maya Ram; Bat-Sheba Porat-Katz; Nicola Bizzaro; Jan Damoiseaux; Jan Willem Cohen Tervaert; Salvatore deVita; Stefano Bombardieri; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 3.  Giant cell arteritis: ophthalmic manifestations of a systemic disease.

Authors:  Elisabeth De Smit; Eoin O'Sullivan; David A Mackey; Alex W Hewitt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-05       Impact factor: 3.117

4.  Cutaneous leukocytoclastic vasculitis associated with mycobacterial and salmonella infection.

Authors:  Sulaiman M Al-Mayouf; Sultan Bahabri; Mahmuod Majeed
Journal:  Clin Rheumatol       Date:  2006-10-05       Impact factor: 2.980

Review 5.  Large vessel vasculitis.

Authors:  Ashima Gulati; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2009-10-17       Impact factor: 3.714

6.  IFN priming is necessary but not sufficient to turn on a migratory dendritic cell program in lupus monocytes.

Authors:  Alicia Rodriguez-Pla; Pinakeen Patel; Holden T Maecker; Jose Rossello-Urgell; Nicole Baldwin; Lynda Bennett; Victoria Cantrell; Jeanine Baisch; Marilynn Punaro; Alisa Gotte; Lorien Nassi; Tracey Wright; Anna Karolina Palucka; Jacques Banchereau; Virginia Pascual
Journal:  J Immunol       Date:  2014-05-14       Impact factor: 5.422

Review 7.  Immune mechanisms in medium and large-vessel vasculitis.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  Nat Rev Rheumatol       Date:  2013-11-05       Impact factor: 20.543

8.  Epstein-Barr virus-related cutaneous necrotizing vasculitis in a girl heterozygous for factor V Leiden.

Authors:  Cristina Guerriero; Gaia Moretta; Giulia Bersani; Piero Valentini; Antonio Gatto; Donato Rigante
Journal:  J Dermatol Case Rep       Date:  2017-12-01

9.  Co-trimoxazole and prevention of relapses of PR3-ANCA positive vasculitis with pulmonary involvement.

Authors:  K Zycinska; K A Wardyn; T M Zielonka; R Krupa; W Lukas
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

10.  Cytomegalovirus-induced immunopathology and its clinical consequences.

Authors:  Stefania Varani; Maria Paola Landini
Journal:  Herpesviridae       Date:  2011-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.